Search results for "Adrenal incidentaloma"

showing 3 items of 3 documents

Adrenal incidentaloma: a new contributing factor in metabolic syndrome?

2004

adrenal incidentaloma
researchProduct

Laparoscopic adrenalectomy: preoperative data, surgical technique and clinical outcomes

2019

Background: laparoscopic adrenalectomy has become the standard treatment for adrenal lesions. The better clinical outcoms of laparoscopic technique are valid for treatment of small benign masses (< 5-6 cm), instead there are still open questions in literature regarding the correct management of larger lesions (> 6 cm) or in case of potentially malignant adrenal tumors. The aim of this study is to evaluate the outcomes of laparoscopic adrenalectomy in a referral surgical department for endocrine surgery. Methods: at the University Hospital Policlinico "P. Giaccone" of Palermo between January 2010 and December 2017 we performed a total of 81 laparoscopic adrenalectomy. We created a retr…

AdultMaleLaparoscopic surgerymedicine.medical_specialtyBlood transfusionmedicine.medical_treatmentOperative TimeAdrenal Gland Neoplasmslcsh:SurgeryLaparoscopic adrenalectomyHemorrhageAdrenal neoplasmAdrenal IncidentalomaLaparoscopic surgeryLesion03 medical and health sciencesPostoperative Complications0302 clinical medicineHumansCushing syndromeMedicinePostoperative PeriodIntraoperative ComplicationsAgedRetrospective StudiesAged 80 and overbusiness.industryResearchPatient SelectionAdrenalectomyStandard treatmentAdrenalectomylcsh:RD1-811General MedicineLength of StayMiddle AgedSurgeryEndocrine surgeryEndocrine surgeryDissection030220 oncology & carcinogenesisFemaleLaparoscopy030211 gastroenterology & hepatologySurgerymedicine.symptombusinessBMC Surgery
researchProduct

Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?

2014

Guidelines for the management of osteoporosis induced by endogenous hypercortisolism are not available. Both the American College of Rheumatology and the International Osteoporosis Foundation recommend to modulate the treatment of exogenous glucocorticoid-induced osteoporosis (GIO) based on the individual fracture risk profile (calculated by FRAX) and dose of glucocorticoid used, but it is difficult to translate corticosteroid dosages to different degrees of endogenous hypercortisolism, and there are no data on validation of FRAX stratification method in patients with endogenous hypercortisolism. Consequently, it is unclear whether such recommendations may be adapted to patients with endoge…

Oncologymedicine.medical_specialtyFRAXEndocrinology Diabetes and MetabolismOsteoporosisHypercortisolismAdrenal incidentaloma; Cushing's disease; Glucocorticoids; Osteoporosis; Bone Density Conservation Agents; Cushing Syndrome; Glucocorticoids; Humans; Osteoporosis; Osteoporotic Fractures; Risk FactorsEndogenyDiseaseadrenal incidentalomaBone remodelingRisk FactorsInternal medicinemedicineHumansCushing SyndromeBone Density Conservation Agentsglucocorticoidsbusiness.industrycushing's diseaseCushing's diseasemedicine.diseaseosteoporosisRheumatologyglucocorticoids; osteoporosis; cushing's disease; adrenal incidentalomaEndocrinologyAdrenal incidentaloma; CUSHING'S DISEASE; Glucocorticoids; OsteoporosisbusinessGlucocorticoidOsteoporotic Fracturesmedicine.drug
researchProduct